Older Men Are as Responsive as Young Men to the Anabolic Effects of Graded Doses of Testosterone on the Skeletal Muscle
The DOI matches its Crossref record; 72 of the 73 references it cites were found in a registry or an index.
Abstract
Although testosterone levels and muscle mass decline with age, many older men have serum testosterone level in the normal range, leading to speculation about whether older men are less sensitive to testosterone. We determined the responsiveness of androgen-dependent outcomes to graded testosterone doses in older men and compared it to that in young men. The participants in this randomized, double-blind trial were 60 ambulatory, healthy, older men, 60-75 yr of age, who had normal serum testosterone levels. Their responses to graded doses of testosterone were compared with previous data in 61 men, 19-35 yr old. The participants received a long-acting GnRH agonist to suppress endogenous testosterone production and 25, 50, 125, 300, or 600 mg testosterone enanthate weekly for 20 wk. Fat-free mass, fat mass, muscle strength, sexual function, mood, visuospatial cognition, hormone levels, and safety measures were evaluated before, during, and after treatment. Of 60 older men who were randomized, 52 completed the study. After adjusting for testosterone dose, changes in serum total testosterone (change, -6.8, -1.9, +16.1, +49.5, and +101.9 nmol/liter at 25, 50, 125, 300, and 600 mg/wk, respectively) and hemoglobin (change, -3.6, +9.9, +20.9, +12.6, and +29.4 g/liter at 25, 50, 125, 300, and 600 mg/wk, respectively) levels were dose-related in older men and significantly greater in older men than young men (each P < 0.0001). The changes in FFM (-0.3, +1.7, +4.2, +5.6, and +7.3 kg, respectively, in five ascending dose groups) and muscle strength in older men were correlated with testosterone dose and concentrations and were not significantly different in young and older men. Changes in fat mass correlated inversely with testosterone dose (r = -0.54; P < 0.001) and were significantly different in young vs. older men (P < 0.0001); young men receiving 25- and 50-mg doses gained more fat mass than older men (P < 0.0001). Mood and visuospatial cognition did not change significantly in either group. Frequency of hematocrit greater than 54%, leg edema, and prostate events were numerically higher in older men than in young men. Older men are as responsive as young men to testosterone's anabolic effects; however, older men have lower testosterone clearance rates, higher increments in hemoglobin, and a higher frequency of adverse effects. Although substantial gains in muscle mass and strength can be realized in older men with supraphysiological testosterone doses, these high doses are associated with a high frequency of adverse effects. The best trade-off was achieved with a testosterone dose (125 mg) that was associated with high normal testosterone levels, low frequency of adverse events, and significant gains in fat-free mass and muscle strength.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There are conflicting data on the effect of testosterone supplementation on muscle strength and function50,51,357,414.”
From Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies (2018) · cites this paper as [414]
In the citing paper
“Testosterone has a dose-dependent impact on fat-free mass in both the young and old, with higher levels associated with reduction in fat mass and increase in skeletal muscle mass and strength [43].”
From Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature Review (2019) · cites this paper as [43]
Citations
Cites
Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
Harman, S. M., Metter, E. J., Tobin, J. D., Pearson, J., & Blackman, M. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7219 · Cited by 2,760
Feldman, H. A., Longcope, C., Derby, C. A., Johannes, C. B., Araujo, A. B., Coviello, A. D., Bremner, W. J., & McKinlay, J. B. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8201 · Cited by 1,861
The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men
Bhasin, S., Storer, T. W., Berman, N., Callegari, C., Clevenger, B., Phillips, J., Bunnell, T. J., Tricker, R., Shirazi, A., & Casaburi, R. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607043350101 · Cited by 1,659
Self-citationAging of skeletal muscle: a 12-yr longitudinal study
Frontera, W. R., Hughes, V. A., Fielding, R. A., Fiatarone, M. A., Evans, W. J., & Roubenoff, R. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.88.4.1321 · Cited by 1,443
GRAY, A., FELDMAN, H. A., MCKINLAY, J. B., & LONGCOPE, C. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-5-1016 · Cited by 1,118
Testosterone dose-response relationships in healthy young men
Bhasin, S., Woodhouse, L., Casaburi, R., Singh, A. B., Bhasin, D., Berman, N., Chen, X., Yarasheski, K. E., Magliano, L., Dzekov, C., et al. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1172 · Cited by 967 · cited 7×
“The characteristics of young men have been described previously (29).”
BackgroundMethodResultInfluentialSelf-citationTestosterone Replacement in Older Hypogonadal Men: A 12-Month Randomized Controlled Trial
Sih, R. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.6.1661 · Cited by 922
Hughes, V. A., Frontera, W. R., Wood, M., Evans, W. J., Dallal, G. E., Roubenoff, R., & Singh, M. A. F. (2001) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/56.5.b209 · Cited by 921
Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women
Iannuzzi-Sucich, M., Prestwood, K. M., & Kenny, A. M. (2002) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/57.12.m772 · Cited by 890
Morley, J. E., Kaiser, F. E., Perry, H. M., Patrick, P., Morley, P. M. K., Stauber, P. M., Vellas, B., Baumgartner, R. N., & Garry, P. J. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90057-3 · Cited by 830
Cited by
Items 401–500 of 554
Timms, M., Botteon, A., Manos, C., Griffin, J., Levina, V., & Steel, R. (2023) · Drug Testing and Analysis · doi:10.1002/dta.3486 · Cited by 5
Abuse of anabolic steroids: A dangerous indulgence
Gagliano‐Jucá, T., & Basaria, S. S. (2019) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2019.10.002 · Cited by 7
Oflazer, P. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)86018-0 · Cited by 4
“There is some indication that older men may be less sensitive to testosterone as many older men have testosterone levels which are still within the normal range (Bhasin et al., 2001; Bhasin et al., 2005).”
BackgroundCancer: evolutionary origins of vulnerability
Greaves, M. F. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0021 · Cited by 7
The evolutionary context of human aging and degenerative disease
Austad, S. N., & Finch, C. E. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0023 · Cited by 6
Endocrine therapies for sarcopenia in older men
Solomon, A., & Bouloux, P. M. (2006) · British Journal of Hospital Medicine · doi:10.12968/hmed.2006.67.9.22000 · Cited by 7
Naranjo, A. R., Krasowski, M. D., Hamdan, A., O’Connor, K., Carter, C. L., Chen, J., & Greene, D. N. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.119676 · Cited by 4
Testosterone: A Review for Orthopaedic Surgeons
Arcand, M. A., Poulin, D., Testa, E. J., & Lemme, N. J. (2024) · JBJS Reviews · doi:10.2106/jbjs.rvw.24.00061 · Cited by 4
Simão, V. A., Lupi, L. A., Leite, G. A. A., Camargo, I. C. C., & Chuffa, L. G. D. A. (2021) · Reproductive Toxicology · doi:10.1016/j.reprotox.2021.05.002 · Cited by 6
Reid, K. F., Storer, T. W., & Bhasin, S. (2023) · Journal of the American Geriatrics Society · doi:10.1111/jgs.18293 · Cited by 4
“Supraphysiologic doses resulting in serum testosterone concentrations above the upper limit of normal yield greater improvements but are associated with a higher frequency of adverse events making them unlikely candidates for long-term clinical use.(10) Changes in muscle power have been less frequently reported but sm…”
BackgroundSelf-citationPavey, H., Polkey, M. I., Bolton, C. E., Cheriyan, J., McEniery, C. M., Wilkinson, I. B., Mohan, D., Casaburi, R. H., Miller, B. E., Tal‐Singer, R., et al. (2023) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2022-001601 · Cited by 4
Self-citationAndrogen Therapy in Adolescents: A Review
Soliman, A. T., & Sanctis, V. D. (2014) · Andrology-Open Access · doi:10.4172/2167-0250.1000124 · Cited by 6
“Androgen deficiency accounts for decreases in lean mass, muscle size, and strength whereas estrogen deficiency accounts for increases in body fat and both contribute to the decline in sexual function [7-14].”
BackgroundSport, hormones et vieillissement
Duclos, M. (2006) · Science & Sports · doi:10.1016/j.scispo.2006.04.001 · Cited by 4
Endocrine therapies for sarcopenia in older men
Solomon, A., & Bouloux, P. M. (2006) · British Journal of Hospital Medicine · doi:10.12968/hmed.2006.67.sup9.22000 · Cited by 4
Morley, J. E., & Thomas, D. R. (2007) · CRC Press eBooks · doi:10.1201/9781420005493-9 · Cited by 4
Clinical Evaluation of Leydig Cell Function
Swerdloff, R. S., & Wang, C. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-453-7_30 · Cited by 4
Exploration of the role of serum factors in maintaining bone mass during hibernation in black bears
Bradford, R. M. (2010) · Digital Commons - Michigan Tech (Michigan Technological University) · doi:10.37099/mtu.dc.etds/286 · Cited by 6
“muscle) [259] and is a substrate for the synthesis of estrogen, a steroid hormone with anabolic effects on bone.”
Duan, M., Hernandez, B., Kronstedt, S., Donato, J., Saffati, G., Parikh, N. N., Khera, M., & Lyon, G. (2025) · Sexual Medicine Reviews · doi:10.1093/sxmrev/qeaf033 · Cited by 3
Santucci, J., Stapleton, P., Perera, M., Ischia, J. J., Murphy, D. G., Bolton, D. M., Lawrentschuk, N., Frydenberg, M., & Sathianathen, N. J. (2025) · British Journal of Urology · doi:10.1111/bju.16870 · Cited by 4
Possibility of small-molecule-based pharmacotherapy for sarcopenia
Watanabe, Y., & Miyagoe‐Suzuki, Y. (2015) · The Journal of Physical Fitness and Sports Medicine · doi:10.7600/jpfsm.4.73 · Cited by 3
Performance Enhancement Drugs and Sports Supplements for Resistance Training
Guimarães‐Ferreira, L., Dantas, W. S., Murai, I. H., Duncan, M. J., & Zanchi, N. E. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-396454-0.00003-5 · Cited by 5
Androgen Effects on the Skeletal Muscle
Bhasin, S., Singh, R., Jasuja, R., & Storer, T. W. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374602-3.00027-4 · Cited by 4
Self-citationCIAFIS – Congresso Internacional de Atividade Física, Nutrição e Saúde
Soares, N. M. M., Dantas, E. H. M., Silva‐Grigoletto, M. E. D., Silva, R. J. D. S., Aidar, F. J. M., Júnior, W. M. D. S., Cabral, B. T., Carneiro, A. L. G., Garrido, N. D., & Reis, V. M. (2018) · Motricidade · doi:10.6063/motricidade.14077 · Cited by 4
Performance-Enhancing Drugs and Sports Supplements for Resistance Training
Guimarães‐Ferreira, L., Cholewa, J. M., Dantas, W. S., Murai, I. H., Duncan, M. J., & Zanchi, N. E. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813922-6.00003-5 · Cited by 3
Testosterone Level and Cause-Specific Mortality in Older Men without Metabolic Syndrome
Laouali, N., Brailly‐Tabard, S., Helmer, C., Ancelin, M., Tzourio, C., Elbaz, A., Guiochon‐Mantel, A., & Canonico, M. (2020) · Epidemiology and Health · doi:10.4178/epih.e2020036 · Cited by 3
“One study hypothesized that high testosterone levels may promote fluid-sodi-um retention in aging men, thereby contributing to the development of high blood pressure and heart failure [19].”
Beyond T-Trials, T4DM and TRAVERSE: the next large testosterone randomized controlled trial
Yeap, B. B., Tran, C., Douglass, C. M., & McNeil, J. J. (2024) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000886 · Cited by 6
Kaufman, J., T'Sjoen, G. G., & Vermeulen, A. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003353.017 · Cited by 3
Orexigenic Agents in Geriatric Clinical Practice
Viswambharan, V., Manepalli, J. N., & Grossberg, G. T. (2013) · Aging Health · doi:10.2217/ahe.12.83 · Cited by 4
Late-onset hypogonadism: evidence for diagnostic criteria
Page, S. T. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.154 · Cited by 3
“This result is consistent with an intervention study that did not show any improvement in aspects of sexual function, cognition or mood with increasing doses of exogenous testosterone after serum levels in the mid-normal range had been achieved”
Single and Combined Effects of Growth Hormone and Testosterone in Healthy Older Men
WELTMAN, A. L., & Veldhuis, J. D. (2006) · Hormone Research in Paediatrics · doi:10.1159/000096623 · Cited by 3
Perspectives on human health and disease from evolutionary and behavioral ecology
Strassmann, B. I., & Mace, R. H. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0009 · Cited by 4
Androgen deficiency in aging men
T'Sjoen, G. G., & Kaufman, J. (2006) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000224805.31695.6a · Cited by 3
Testosterone Replacement Therapy in Men and Women
El‐Maouche, D., & Dobs, A. S. (2010) · Principles of Gender-Specific Medicine · doi:10.1016/b978-0-12-374271-1.00060-5 · Cited by 5
Králik, M., Cvečka, J., Buzgó, G., Putala, M., Ukropcová, B., Ukropec, J., Killinger, Z., Payer, J., Kollárik, B., Bujdák, P., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-025991 · Cited by 3
Musculoskeletal Rehabilitation for the Aging Female
Abreu-Sosa, S. M., Sullivan, C. M., & Dugan, S. A. (2020) · Current Physical Medicine and Rehabilitation Reports · doi:10.1007/s40141-020-00285-1 · Cited by 3
Gordon, B. S., Rossetti, M. L., & Casero, R. A. (2020) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2020-0404 · Cited by 3
Sarcopenia and Androgens: A Link Between Pathology and Treatment
Basualto-Alarcón, C., Varela, D., Duran, J., Maass, R., & Estrada, M. (2016) · Apple Academic Press eBooks · doi:10.1201/b19985-16 · Cited by 4
The Complex Relation between Muscle Mass and Muscle Strength
Manini, T. M., Russ, D. W., & Clark, B. C. (2012) · Wiley eBooks · doi:10.1002/9781118338032.ch6 · Cited by 4
Morgentaler, A., & Traish, A. M. (2020) · Korean journal of urology · doi:10.4111/icu.2020.61.4.452 · Cited by 3
“[10], in which groups of men received widely varying doses of T injections after suppression of endogenous T via luteinizing hormonereleasing hormone agonist, resulting in serum T concentrations ranging from low to more than twice the upper limit of normal.”
BackgroundImperatore, A., Mennitti, C., Fonzo, G. D., Amitrano, R., Gentile, A., Calvanese, M., IAFUSCO, F., Coppola, S., Digno, M., Borrelli, P., et al. (2025) · Genes · doi:10.3390/genes16111309 · Cited by 5
“Testosterone, together with more potent metabolites such as dihydrotestosterone (DHT), binds to the androgen receptor, especially in muscle tissue, promoting proteins synthesis and muscle growth [275,276].”
Effect of real-world androgen abuse on body composition: a prospective cohort study
Verdegaal, T. J., Bond, P., de Ronde, W., & Smit, D. L. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag142 · Cited by 1
Testosterone therapy is trending. Who really needs it, and why?
Lenharo, M. (2026) · Nature · doi:10.1038/d41586-026-01408-9 · Cited by 2
Barsky, S. T., & Monks, D. A. (2024) · Endocrinology · doi:10.1210/endocr/bqae012 · Cited by 3
Ma, Y., Wang, H., Yang, H., Hong, W., Xu, H., Chen, L., Zhang, B., Ji, C., & Xia, Y. (2025) · Food & Function · doi:10.1039/d4fo03732d · Cited by 3
Testosterone, estradiol and men, and sex hormone binding globulin
Hogervorst, E., Henderson, V. W., Gibbs, R. B., & Brinton, R. D. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511635700.020 · Cited by 2
Androgen Replacement Therapy in Hypogonadal Men
Čeponis, J., Swerdloff, R. S., & Wang, C. (2017) · Springer eBooks · doi:10.1007/978-3-319-53298-1_18 · Cited by 2
Nazarian, A., Azarbayjani, M. A., Atashak, S., & Peeri, M. (2022) · Andrologia · doi:10.1111/and.14394 · Cited by 2
Testosterone: clinical relevance in ageing men
Huupponen, R., Huhtaniemi, I. T., & Lehtonen, A. (2009) · Reviews in Clinical Gerontology · doi:10.1017/s0959259809990372 · Cited by 2
Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2010) · Cited by 4
Self-citationHealth consequences of ecogenetic variation
Bamshad, M. J., & Motulsky, A. G. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0004 · Cited by 2
Utility and Limitations in Measuring Testosterone
Grossmann, M. (2017) · Springer eBooks · doi:10.1007/978-3-319-46086-4_4 · Cited by 3
Testosterone and Physical Function
Yalamanchi, S., Kalyani, R. R., Buta, B. J., & Dobs, A. S. (2017) · Current Sexual Health Reports · doi:10.1007/s11930-017-0136-z · Cited by 2
Serum Testosterone Concentrations in Older Men: One Size Does Not Fit All
Grossmann, M. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa400 · Cited by 2
Management of Testosterone Deficiency in the Aging Male
Corradi, P., Corradi, R., & Greene, L. (2020) · Springer eBooks · doi:10.1007/978-3-030-54482-9_8
Gamidov, S. I., Тажетдинов, О. Х., Pavlovichev, A., Попова, А. Ю., & Тхагапсоева, Р. А. (2010) · Problems of Endocrinology · doi:10.14341/probl201056533-42 · Cited by 3
Health promotion and quality of life 2
de Oliveira, A. M. C. (2022) · doi:10.22533/at.ed.416222211 · Cited by 2
Testosterone replacement and cardiovascular disease risk: what do endocrinologists need to know?
Gonzalez, J. R., & Goldstein, I. (2015) · Cardiovascular Endocrinology · doi:10.1097/xce.0000000000000051 · Cited by 2
Morgentaler, A., Zitzmann, M., Traish, A. M., Fox, A. W., Jones, T. H., Maggi, M., Arver, S., Aversa, A., Chan, J. C. N., Dobs, A. S., et al. (2016) · Obesity and metabolism · doi:10.14341/omet2016315-31 · Cited by 2
Adverse Outcomes and Functional Consequences of Sarcopenia
Thomas, D. R. (2012) · Wiley eBooks · doi:10.1002/9781118338032.ch8 · Cited by 4
Practice Guidelines ACCP/AACVPR Evidence-Based Clinical Pulmonary Rehabilitation: Joint
ZuWallack, R., Herrerias, C. T., Emery, C. F., Mahler, D. A., Make, B. J., Rochester, C. L., Ries, A. L., Bauldoff, G. S., Carlin, B. W., & Casaburi, R. H. (2007) · Cited by 2
Self-citationEvolutionary origins of diversity in human viruses
Sharp, P. M., Bailes, E., & Wain, L. V. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0013 · Cited by 2
Toward Healthy Aging: A Clinical Trial Builds on Mechanistic Insights
Yeap, B. B. (2023) · The Journals of Gerontology Series A · doi:10.1093/gerona/glac200 · Cited by 3
Benefits and Risks of Testosterone Therapy in Men With Testosterone Deficiency
Traish, A. M., & Morgentaler, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813197-8.00018-x · Cited by 2
Sporda Dayanıklılık ve Aerobik Dayanıklılık Testleri
Atasever, G., & Kıyıcı, F. (2024) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub640.c2773 · Cited by 1
Egzersizde Protein Sentezi ve Etkileyen Faktörler
Akkuş, E. (2024) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub640.c2771 · Cited by 1
Impact of Testosterone Deficiency and Testosterone Therapy on Men’s Health
Traish, A. M. (2025) · Springer eBooks · doi:10.1007/978-3-031-89650-7_13 · Cited by 1
Algal nutraceuticals: a potential alternative to health supplementation for athletes
Kumawat, K. R., Pareek, A., & Singh, N. (2025) · Sport Sciences for Health · doi:10.1007/s11332-025-01545-0 · Cited by 2
“Testosterone administration has been demonstrated to dose dependently manner; it enhances muscle mass strength in both young and older men [221, 222] and young women [223].”
Atherton, P. J., Hu, K., Jones, B., Cheung, A. S.-Z., Costa, R. J. S., Eynon, N., Seto, J. T., Moesgaard, L., Hostrup, M., Lima, G. H. O., et al. (2026) · Frontiers in Sports and Active Living · doi:10.3389/fspor.2025.1735032 · Cited by 1
Marriott, R. J., Murray, K., Antonio, L., Adams, R. J., Ballantyne, C. M., Bauer, D. C., Bhasin, S., Biggs, M. L., Cawthon, P. M., Couper, D. J., et al. (2026) · The Lancet Healthy Longevity · doi:10.1016/j.lanhl.2026.100857 · Cited by 2
Self-citationTestosterone Therapy for Osteoporosis in Men
Lakshman, K. M., Bhasin, S., & Araujo, A. B. (2010) · Osteoporosis in Men · doi:10.1016/b978-0-12-374602-3.00056-0 · Cited by 1
Self-citationTestosterone replacement therapy and the prostate
Tenover, J. L. (2007) · Current Sexual Health Reports · doi:10.1007/s11930-007-0006-1 · Cited by 1
Testosterone replacement therapy: Take an informed, individualized approach
Coplan, B. H., Spiegel, J. J., Bleaman, I., & Roch, J. (2011) · JAAPA · doi:10.1097/01720610-201101000-00009 · Cited by 1
Adipositas und Hypogonadismus: Resultate der Testosteron-Therapie
Saad, F. (2016) · Adipositas - Ursachen Folgeerkrankungen Therapie · doi:10.1055/s-0037-1617716 · Cited by 2
“Die Abhängigkeit der Zunahme an Muskelmasse von der Testosteron-Dosis konnte in einer 20-wöchigen Vergleichsstudie mit aufsteigenden Dosisgruppen eindrucksvoll gezeigt werden (6).”
BackgroundJankowska, E. A., Tkaczyszyn, M., Węgrzynowska‐Teodorczyk, K., Majda, J., von Haehling, S., Doehner, W., Banasiak, W., Anker, S. D., & Ponikowski, P. P. (2014) · ESC Heart Failure · doi:10.1002/2055-5822.12002 · Cited by 1
Pan, Y., & Ma, L. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823761-8.00004-5 · Cited by 2
Wang, W., Ren, R., Yang, H., Jiang, J., Ye, X., Wang, C., Ji, X., Li, W., Zhao, Y., Xia, Y., et al. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.125.041697 · Cited by 1
Andrew, B., Rao, S., Samuele, M., Casanova, F., & Peter, J. (2013) · InTech eBooks · doi:10.5772/53236 · Cited by 4
“In support of this treatment strategy, studies utilising either replacement or supraphysiologic doses of testosterone or AAS have been shown to elicit significant increases in lean/muscle mass and reductions in fat mass in healthy, young, middle-aged and old androgen-deficient men [20,21,22-29], frail elderly men [30]…”
MethodDoping Status of DHEA Treatment for Female Athletes with Adrenal Insufficiency
Handelsman, D. J., Matsumoto, A. M., & GERRARD, D. F. (2016) · Clinical Journal of Sport Medicine · doi:10.1097/jsm.0000000000000300 · Cited by 3
Chin, K. (2019) · Medicine & health · doi:10.17576/mh.2019.1402.15 · Cited by 2
The Interplay of Muscle and Bone in Later Life
Laskou, F., Dennison, E. M., & Patel, H. P. (2021) · Springer eBooks · doi:10.1007/978-3-030-78128-6_10 · Cited by 2
Iyer, R., & Handelsman, D. J. (2023) · Springer eBooks · doi:10.1007/978-3-031-31501-5_23 · Cited by 1
Landis, J. A., & Ziegenfuss, T. N. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-302-8_23 · Cited by 1
Long-Term Morbidity of Late-Onset Hypogonadism
Behre, H. M. (2005) · European Urology Supplements · doi:10.1016/j.eursup.2005.05.003 · Cited by 1
Andropause: Need for concrete guidelines until more evidence becomes available
Basaria, S. S. (2005) · Journal of Endocrinological Investigation · doi:10.1007/bf03347269 · Cited by 1
Opportunities for development of novel therapies targeting steroid hormone receptors
Bai, C., Flores, O. A., & Schmidt, A. (2007) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2.5.725 · Cited by 1
“The benefits of anabolic androgens on the musculoskeletal system in both men and women have long been recognized [49-51] .”
BackgroundCancer as a microevolutionary process
Komarova, N. L., & Wodarz, D. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0022 · Cited by 2
Whole-genome analysis of pathogen evolution
Parkhill, J. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0015 · Cited by 1
Short, K. R. (2006) · CRC Press eBooks · doi:10.1201/9781420019322.ch18 · Cited by 1
Henkies, D. (2020) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7868 · Cited by 3
Haren, M. T., & Morley, J. E. (2007) · Nutrition and disease prevention · doi:10.1201/9781420005493.ch5 · Cited by 1
The interrelationship of sex steroid levels, body composition and bone characteristics in men
Lapauw, B. (2009) · Ghent University Academic Bibliography (Ghent University)
Buisson, J. (2010) · Les cahiers de l année gérontologique · doi:10.1007/s12612-010-0062-4
Maki, P. M. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511635700.023
Meikle, A. W. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00183-8 · Cited by 1
Promotion of “Low T” and the Role of Testosterone Clinical Trials
Schooling, C. M., Leung, G. M., & Xu, L. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.12750
Roundtable Discussion: Anabolic Androgenic Steroids: Part I
Haff, G. G. (2006) · Strength and conditioning journal · doi:10.1519/1533-4295(2006)28[42:rdaasp]2.0.co;2
Male hormonal contraception: a safe option?
Walton, M. J., & Anderson, R. A. (2006) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.1.1.25
For information on reprint requests of more than 101 and commercial reprints contact
Barbour, L. A., Cobin, R. H., DeGroot, L. J., Glinoer, D., Mandel, S. J., & Edwards, H. A. (2008)
Antiaging Medicine: What Should We Tell Our Patients?
Perls, T. T. (2010) · Aging Health · doi:10.2217/ahe.10.11
Papadopoulos, N. G., Bavbek, S., Čustović, A., Eigenmann, P., Hellings, P. W., Muraro, A. M., Poulsen, L. K., Roberts, G. C., Schmid‐Grendelmeier, P., Werfel, T., et al. (2014)
Metadata
- Authors
- Bhasin, S., Woodhouse, L., Casaburi, R., Singh, A. B., Mac, R. P., Lee, M., Yarasheski, K. E., Sinha-Hikim, I., Dzekov, C., Dzekov, J., Magliano, L., & Storer, T. W.
- Affiliations
- University of California, Los Angeles (US)
- Charles R. Drew University of Medicine and Science (US)
- Washington University in St. Louis (US)
- El Camino College (US)
- Corresponding author
- Bhasin, Shalender
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-02
- Volume
- 90
- Issue
- 2
- Pages
- 678-688
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2133467178
- Cited by
- 544
- References
- 73
- Citations by year
- 2026: 7 · 2025: 15 · 2024: 23 · 2023: 16 · 2022: 30 · 2021: 13 · 2020: 19 · 2019: 17 · 2018: 30 · 2017: 28 · 2016: 17 · 2015: 19 · 2014: 22 · 2013: 29 · 2012: 22
- FWCI
- 28.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p41rr000954-34, 5u01dk054047-06)
- National Institute on Aging (1R01 AG-14369-01, R01AG014369)
- National Institute of General Medical Sciences (GM-00425)
- National Institute of Diabetes and Digestive and Kidney Diseases (1R01 DK 59627-01, U01-DK-54047, R01DK049296, 2R01DK49296-02A, R01DK059627)
- National Center for Research Resources (G12 RR 03026, P41-RR000954, P20RR11145, 5P41-RR-000954, G12RR003026, P20RR011145)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD041748, R01HD043348)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
- Keywords
- older men, androgen response, skeletal muscle, fat-free mass, fat mass, muscle strength, sexual function, mood, visuospatial cognition, GnRH agonist, testosterone replacement therapy, aging, hemoglobin response, adverse effects, treatment discontinuation
- MeSH terms
- Adult, Age Factors, Aged, Aging, Energy Intake, Exercise Test, Humans, Luteinizing Hormone, Male, Middle Aged, Sexual Behavior, Sex Hormone-Binding Globulin, Testosterone, Leuprolide, Muscle, Skeletal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.